Jon Fyrwald Erik's Insider Trades & SAST Disclosures
Jon Fyrwald Erik's most recent trade in Lilly(Eli) & Co was a trade of 13 Common Stock done at an average price of $762.8 . Disclosure was reported to the exchange on May 19, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Jon Fyrwald Erik.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lilly(Eli) & Co | Jon Erik Fyrwald | Director | Grant, award, or other acquisition of securities at price $ 762.85 per share. | 19 May 2025 | 13 | 72,852 (0%) | 0% | 762.8 | 9,917 | Common Stock |
| International Flavors & Fr... | Jon Erik Fyrwald | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 73.97 per share. | 08 May 2025 | 24,300 | 62,070 (0%) | 0% | 74.0 | 1,797,456 | Common Stock |
| International Flavors & Fr... | Jon Erik Fyrwald | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 74.00 per share. | 08 May 2025 | 700 | 37,770 (0%) | 0% | 74.0 | 51,797 | Common Stock |
| International Flavors & Fr... | Jon Erik Fyrwald | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2025 | 15,875 | 88,059 | - | - | Restricted Stock Units | |
| International Flavors & Fr... | Jon Erik Fyrwald | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2025 | 15,875 | 45,175 (0%) | 0% | 0 | Common Stock | |
| International Flavors & Fr... | Jon Erik Fyrwald | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.85 per share. | 01 May 2025 | 8,105 | 37,070 (0%) | 0% | 77.8 | 630,974 | Common Stock |
| Lilly(Eli) & Co | Jon Erik Fyrwald | Director | Grant, award, or other acquisition of securities at price $ 826.42 per share. | 21 Apr 2025 | 12 | 72,839 (0%) | 0% | 826.4 | 9,917 | Common Stock |
| International Flavors & Fr... | Jon Erik Fyrwald | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 56,309 | 103,934 | - | - | Restricted Stock Units | |
| Lilly(Eli) & Co | Jon Erik Fyrwald | Director | Grant, award, or other acquisition of securities at price $ 826.42 per share. | 17 Mar 2025 | 12 | 72,827 (0%) | 0% | 826.4 | 9,917 | Common Stock |
| International Flavors & Fr... | Jon Erik Fyrwald | Director, CEO | Purchase of securities on an exchange or from another person at price $ 80.24 per share. | 04 Mar 2025 | 25,000 | 29,300 (0%) | 0% | 80.2 | 2,005,878 | Common Stock |
| Lilly(Eli) & Co | Jon Erik Fyrwald | Director | Grant, award, or other acquisition of securities at price $ 901.55 per share. | 18 Feb 2025 | 11 | 72,683 (0%) | 0% | 901.5 | 9,917 | Common Stock |
| Lilly(Eli) & Co | Jon Erik Fyrwald | Director | Grant, award, or other acquisition of securities at price $ 762.77 per share. | 21 Jan 2025 | 13 | 72,671 (0%) | 0% | 762.8 | 9,916 | Common Stock |
| Lilly(Eli) & Co | Jon Erik Fyrwald | Director | Grant, award, or other acquisition of securities at price $ 728.40 per share. | 18 Nov 2024 | 320 | 72,540 (0%) | 0% | 728.4 | 233,089 | Common Stock |
| International Flavors & Fr... | Jon Erik Fyrwald | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2024 | 47,625 | 47,625 | - | - | Restricted Stock Units | |
| International Flavors & Fr... | Jon Erik Fyrwald | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 56,250 | 56,250 | - | - | Restricted Stock Units | |
| Lilly(Eli) & Co | Jon Fyrwald Erik | Director | Grant, award, or other acquisition of securities at price $ 579.76 per share. | 18 Dec 2023 | 17 | 71,886 (0%) | 0% | 579.8 | 9,856 | Common Stock |
| Lilly(Eli) & Co | Jon Erik Fyrwald | Director | Grant, award, or other acquisition of securities at price $ 597.60 per share. | 20 Nov 2023 | 335 | 71,736 (0%) | 0% | 597.6 | 200,196 | Common Stock |
| Lilly(Eli) & Co | Jon Erik Fyrwald | Director | Grant, award, or other acquisition of securities at price $ 597.59 per share. | 20 Nov 2023 | 17 | 71,401 (0%) | 0% | 597.6 | 10,159 | Common Stock |
| Lilly(Eli) & Co | Jon Erik Fyrwald | Director | Grant, award, or other acquisition of securities at price $ 616.62 per share. | 16 Oct 2023 | 16 | 71,384 (0%) | 0% | 616.6 | 9,866 | Common Stock |
| Lilly(Eli) & Co | Jon Erik Fyrwald | Director | Grant, award, or other acquisition of securities at price $ 571.29 per share. | 18 Sep 2023 | 17 | 71,368 (0%) | 0% | 571.3 | 9,712 | Common Stock |
| Lilly(Eli) & Co | Jon Erik Fyrwald | Director | Grant, award, or other acquisition of securities at price $ 550.50 per share. | 21 Aug 2023 | 18 | 71,214 (0%) | 0% | 550.5 | 9,909 | Common Stock |
| Lilly(Eli) & Co | Jon Erik Fyrwald | Director | Grant, award, or other acquisition of securities at price $ 447.14 per share. | 17 Jul 2023 | 22 | 71,196 (0%) | 0% | 447.1 | 9,837 | Common Stock |
| Lilly(Eli) & Co | Jon Erik Fyrwald | Director | Grant, award, or other acquisition of securities at price $ 451.95 per share. | 20 Jun 2023 | 22 | 71,174 (0%) | 0% | 452.0 | 9,943 | Common Stock |
| Lilly(Eli) & Co | Jon Erik Fyrwald | Director | Grant, award, or other acquisition of securities at price $ 434.52 per share. | 15 May 2023 | 23 | 70,972 (0%) | 0% | 434.5 | 9,994 | Common Stock |
| Lilly(Eli) & Co | Jon Erik Fyrwald | Director | Grant, award, or other acquisition of securities at price $ 372.33 per share. | 17 Apr 2023 | 27 | 70,949 (0%) | 0% | 372.3 | 10,053 | Common Stock |
| Lilly(Eli) & Co | Jon Erik Fyrwald | Director | Grant, award, or other acquisition of securities at price $ 333.60 per share. | 20 Mar 2023 | 30 | 70,922 (0%) | 0% | 333.6 | 10,008 | Common Stock |
| Bunge Ltd. | Jon Erik Fyrwald | Director | Grant, award, or other acquisition of securities at price $ 96.42 per share. | 02 Mar 2023 | 12 | 7,349 (0%) | 0% | 96.4 | 1,157 | Common Stock |
| Lilly(Eli) & Co | Jon Erik Fyrwald | Director | Grant, award, or other acquisition of securities at price $ 327.50 per share. | 21 Feb 2023 | 30 | 70,639 (0%) | 0% | 327.5 | 9,825 | Common Stock |
| Lilly(Eli) & Co | Jon Erik Fyrwald | Director | Grant, award, or other acquisition of securities at price $ 357.75 per share. | 17 Jan 2023 | 28 | 70,609 (0%) | 0% | 357.8 | 10,017 | Common Stock |
| Lilly(Eli) & Co | Jon Erik Fyrwald | Director | Grant, award, or other acquisition of securities at price $ 357.79 per share. | 19 Dec 2022 | 28 | 70,581 (0%) | 0% | 357.8 | 10,018 | Common Stock |
| Lilly(Eli) & Co | Jon Erik Fyrwald | Director | Grant, award, or other acquisition of securities at price $ 361.17 per share. | 21 Nov 2022 | 498 | 70,362 (0%) | 0% | 361.2 | 179,863 | Common Stock |
| Lilly(Eli) & Co | Jon Erik Fyrwald | Director | Grant, award, or other acquisition of securities at price $ 361.19 per share. | 21 Nov 2022 | 27 | 69,864 (0%) | 0% | 361.2 | 9,752 | Common Stock |
| Lilly(Eli) & Co | Jon Erik Fyrwald | Director | Grant, award, or other acquisition of securities at price $ 332.77 per share. | 17 Oct 2022 | 30 | 69,837 (0%) | 0% | 332.8 | 9,983 | Common Stock |
| Lilly(Eli) & Co | Jon Erik Fyrwald | Director | Grant, award, or other acquisition of securities at price $ 305.09 per share. | 19 Sep 2022 | 33 | 69,807 (0%) | 0% | 305.1 | 10,068 | Common Stock |
| Lilly(Eli) & Co | Jon Erik Fyrwald | Director | Grant, award, or other acquisition of securities at price $ 313.94 per share. | 15 Aug 2022 | 32 | 69,560 (0%) | 0% | 313.9 | 10,046 | Common Stock |
| Lilly(Eli) & Co | Jon Erik Fyrwald | Director | Grant, award, or other acquisition of securities at price $ 321.77 per share. | 18 Jul 2022 | 31 | 69,528 (0%) | 0% | 321.8 | 9,975 | Common Stock |
| Lilly(Eli) & Co | Jon Erik Fyrwald | Director | Grant, award, or other acquisition of securities at price $ 297.33 per share. | 21 Jun 2022 | 33 | 69,497 (0%) | 0% | 297.3 | 9,812 | Common Stock |
| Lilly(Eli) & Co | Jon Erik Fyrwald | Director | Grant, award, or other acquisition of securities at price $ 299.39 per share. | 16 May 2022 | 33 | 69,236 (0%) | 0% | 299.4 | 9,880 | Common Stock |
| Lilly(Eli) & Co | Jon Erik Fyrwald | Director | Grant, award, or other acquisition of securities at price $ 298.82 per share. | 18 Apr 2022 | 33 | 69,203 (0%) | 0% | 298.8 | 9,861 | Common Stock |
| Lilly(Eli) & Co | Jon Erik Fyrwald | Director | Grant, award, or other acquisition of securities at price $ 289.65 per share. | 21 Mar 2022 | 34 | 69,170 (0%) | 0% | 289.6 | 9,848 | Common Stock |
| Lilly(Eli) & Co | Jon Erik Fyrwald | Director | Grant, award, or other acquisition of securities at price $ 239.12 per share. | 22 Feb 2022 | 41 | 68,883 (0%) | 0% | 239.1 | 9,804 | Common Stock |
| Lilly(Eli) & Co | Jon Erik Fyrwald | Director | Grant, award, or other acquisition of securities at price $ 247.08 per share. | 18 Jan 2022 | 40 | 68,842 (0%) | 0% | 247.1 | 9,883 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges